Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Oral administration is the most commonly used and readily accepted form of drug delivery; however, it is find that many drugs are difficult to attain enough bioavailability when administered via this route. Polymeric micelles (PMs) can overcome some limitations of the oral delivery acting as carriers able to enhance drug absorption, by providing (1) protection of the loaded drug from the harsh environment of the GI tract, (2) release of the drug in a controlled manner at target sites, (3) prolongation of the residence time in the gut by mucoadhesion, and (4) inhibition of efflux pumps to improve the drug accumulation. To explain the mechanisms for enhancement of oral bioavailability, we discussed the special stability of PMs, the controlled release properties of pH-sensitive PMs, the prolongation of residence time with mucoadhesive PMs, and the P-gp inhibitors commonly used in PMs, respectively. The primary purpose of this paper is to illustrate the potential of PMs for delivery of poorly water-soluble drugs with bioavailability being well maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the mechanisms involved in the absorption of exogenous drugs in the small intestine. (a) Transcellular transport; (b) active transport; (c) facilitated diffusion; (d) receptor-mediated endocytosis; (e) paracellular transport; (f) pinocytosis [3].](https://figures.cochat.ai/paper-figures/f760f35972f34f1c8e324112b058d11c/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-1.jpg)


![Figure 4 Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].](https://figures.cochat.ai/paper-figures/292163f5bd3e4a15b3eb9e18032f118f/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 3×
“Pgp is a 170-kDa membrane transporter which is part of the ATP-binding cassette (ABC) [150].”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“Besides, approximately 40% of currently marketed immediate-release oral drugs are considered practically insoluble (solubility less than 100 μg/mL) in water [6, 7].”
BackgroundImpact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348 · cited 2×
“macromolecules [12, 13].”
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 2×
“Blends of this polymer with polyethylacrylate (PMAA-PEA) and polymethacrylate (PMAA-PMA) can be tailored to dissolve in specific pH ranges corresponding to specific locations in the GI tract [100–102].”
BackgroundMicellization of block copolymers
Riess, G. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00015-7 · Cited by 1,953 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 1×
“Mucoadhesion can be obtained by the building of either nonspecific interactions with the mucosal surface, such as covalent bonds, ionic bonds, hydrogen bonding, and van der Waals’ interactions [117], or specific interactions by functionalizing polymers with targeting ligands (e.”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623 · cited 1×
“Intrinsic properties of drugs such as poor stability in the gastric environment, lowmucosal permeability, and low solubility in the mucosal fluids will contribute to low absorption [26, 27].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 3×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundMethodCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459 · cited 1×
“The luminal surface of mucosal tissues is protected by a highly viscoelastic layer [110], and the protective coatings rapidly remove foreign particles from the GI tract which probably lead to low bioavailability.”
Background
Research works printed but not linked: 2
- Lee ES Shin HJ Na K Bae YH Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization Journal of Controlled Release 2003 90 3 363 374 2-s2.0-0038106270 12880703 · DOI · Paper page
- Mo R Jin X Li N The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 2011 32 20 4609 4620 2-s2.0-79955522520 21440934 · DOI · Paper page
Cited by
Items 301–400 of 620
Rao, D. A., Nguyen, D. X., Mishra, G. P., Doddapaneni, B. S., & Alani, A. W. G. (2015) · Journal of Visualized Experiments · doi:10.3791/53047 · Cited by 15
Tam, Y. T., Repp, L., Ma, Z., Feltenberger, J. B., & Kwon, G. S. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2600-0 · Cited by 14
Self-assembled block copolymers in ionic liquids: Recent advances and practical applications
Ghorbanizamani, F., Moulahoum, H., Zihnioğlu, F., & Tımur, S. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.115076 · Cited by 15
Arya, P., Sharma, M. R., & Raghav, N. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141929 · Cited by 14
Nanostructured Biomaterials in Drug Delivery: Current Trends and Upcoming Possibilities
Sharma, P. (2023) · Engineering materials · doi:10.1007/978-981-99-6698-1_9 · Cited by 23
Niroula, A., Alharrasi, S., Aldhaheri, M., Rabbani, A., Ali, A., & Nazir, A. (2024) · LWT · doi:10.1016/j.lwt.2024.116732 · Cited by 13
Hu, H., Zhou, H., Zhen, Z., Wu, Z., Zhang, R., & Xu, D. (2019) · ChemistrySelect · doi:10.1002/slct.201902562 · Cited by 13
Cheng, C., Sun, Y.-T., Lee, A.-W., Huang, S.-Y., Fan, W.-L., Chiao, Y., Tsai, H., & Lai, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00644 · Cited by 13
Meena, P., & Kishore, N. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116718 · Cited by 13
Yu, Y., Huo, M., Fu, Y., Xu, W., Cai, H., Yao, L., Chen, Q., Mu, Y., Zhou, J., & Yin, T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00662 · Cited by 13
Self-citationTalik, P., Moskal, P., Kucharska, M., Proniewicz, L. M., & Wesełucha‐Birczyńska, A. (2023) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2023.136452 · Cited by 12
Grossen, P., Québatte, G., Witzigmann, D., Prescianotto‐Baschong, C., Dieu, L., & Huwyler, J. (2016) · Journal of Nanomaterials · doi:10.1155/2016/7818501 · Cited by 13
“Additionally, the kinetic stability of the core structure of SNPs is high and thus the disassembly of SNPs after dilution below the CAC occurs slowly allowing an efficient retention of their drug payload [40].”
BackgroundMultifunctional Patented Nanotherapeutics for Cancer Intervention: 2010- Onwards
Pandey, P., Chopra, H., Kaushik, D. K., Verma, R., Purohit, D., Parashar, J., Mittal, V., Rahman, M. H., Bhatia, S., Kumar, P., et al. (2022) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892817666220322085942 · Cited by 12
Davarnejad, R., Layeghy, K., Soleymani, M., & Ayazi, A. (2022) · Chemical Engineering & Technology · doi:10.1002/ceat.202200025 · Cited by 12
Polymeric Nanomaterials: Fundamentals and Therapeutic Applications
Maji, I., Mahajan, S., Sriram, A., Mehra, N. K., & Singh, P. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-30529-0_2 · Cited by 13
Phage-derived protein-mediated targeted chemotherapy of pancreatic cancer
Wang, T., Narayanaswamy, R., Ren, H., Gillespie, J. W., Petrenko, V. A., & Torchilin, V. P. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1405424 · Cited by 14
“Loading such therapeutic agents into the hydrophobic core of micelle can dramatically increase drug solubility, half-life, and bioavailability[4].”
BackgroundA comprehensive review on polymeric micelles: a promising drug delivery carrier
Kumar, A. (2021) · Journal of Analytical & Pharmaceutical Research · doi:10.15406/japlr.2021.10.00372 · Cited by 12
Boon‐in, S., Theerasilp, M., & Crespy, D. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.04.029 · Cited by 12
Drug Delivery to the Lymphatic System
Yang, Q., & Forrest, L. M. (2016) · Wiley eBooks · doi:10.1002/9781118833322.ch21 · Cited by 14
Interaction of Tretinoin and Nimesulide with Amylose Matrices
Marinopoulou, A., Christofilos, D., Arvanitidis, J., & Raphaelides, S. N. (2020) · Starch - Stärke · doi:10.1002/star.202000054 · Cited by 12
Shin, Y. S., Choi, J., Yoon, M., Yoo, M. K., Shin, D. H., & Lee, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s468935 · Cited by 12
“30 Using polymeric micelle formations presents a plausible method for augmenting the solubility and stability of hydrophobic medications 31,32 Polymeric micelles exhibit high solubility, 33,34 loading capacity, 35 blood flow stability, 36,37 and therapeutic potential.”
MethodDiscovery of novel MLK4 inhibitors against colorectal cancer through computational approaches
Akash, S., Shanto, S. K., Islam, M. R., Bayıl, İ., Afolabi, S. O., Guendouzi, A., Abdellattif, M. H., & Zaki, M. E. A. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.109136 · Cited by 12
Sumera, S., Mirza, R., Shah, K. U., & Rehman, A. U. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106257 · Cited by 15
Kamaria, P., Tiwari, P., Prabhakaran, P., Bhardwaj, S., Kolachi, K. Y., & Thapa, S. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70857 · Cited by 12
“Additionally, polymeric micelles or phytosome complexes could be considered to improve oral bioavailability and therapeutic index (Barani et al. 2021; Chen et al. 2024; Xu et al. 2013).”
Addressing Solubility through Nano Based Drug Delivery Systems
Zaman, H. (2016) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000376 · Cited by 13
“At the CAC or CMC, hydrophobic segments of block copolymers start to associate to minimise the contact with water molecules, leading to the formation of a vesicular or core shell micellar structure [32].”
BackgroundStructural and therapeutic properties of salicylic acid-solubilized Pluronic solutions and hydrogels
Ganguly, R., Kumar, S., Soumya, M., Khare, A., Bhainsa, K. C., Aswal, V. K., & Kohlbrecher, J. (2024) · Soft Matter · doi:10.1039/d4sm00079j · Cited by 11
Nerantzaki, M., Adam, K., Koliakou, I. G., Skoufa, E., Avgeropoulos, A., Papageorgiou, G. Z., & Bikiaris, D. Ν. (2017) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201700305 · Cited by 11
The State of the Art of Investigational and Approved Nanomedicine Products for Nucleic Acid Delivery
Paredes, K. O., Ruíz-Cabello, J., Alarcón, D. I., & Filice, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00015-0 · Cited by 12
Preparation and Characterization of Micelles
Patravale, V. B., Upadhaya, P. G., & Jain, R. D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9516-5_2 · Cited by 14
Weng, M., Elsyed, A. F. N., Yang, P., Mohamed, M. G., Kuo, S., & Lin, K. (2022) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2022.104238 · Cited by 11
Singh, M., Rana, N. K., Muthu, M. S., Jha, A., Baul, T. S. B., & Koch, B. (2022) · Materials Today Communications · doi:10.1016/j.mtcomm.2022.103256 · Cited by 12
How Advanced are Cancer Immuno-Nanotherapeutics? A Comprehensive Review of the Literature
Yadav, D., Puranik, N., Meshram, A., Chavda, V. K., Lee, P. C.-W., & Jin, J. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s388349 · Cited by 14
Polymeric Prodrugs Containing Metal-Based Anticancer Drugs
Aderibigbe, B. A. (2015) · Journal of Inorganic and Organometallic Polymers and Materials · doi:10.1007/s10904-015-0220-7 · Cited by 11
Tonglairoum, P., Woraphatphadung, T., Ngawhirunpat, T., Rojanarata, T., Akkaramongkolporn, P., Sajomsang, W., & Opanasopit, P. (2016) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2016.1163391 · Cited by 12
Moholkar, D. N., Sadalage, P. S., Havaldar, D. V., & Pawar, K. D. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.111979 · Cited by 11
Banik, S., Sato, H., & Onoue, S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.103065 · Cited by 10
Venturini, M. (2014) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000211 · Cited by 10
“In particular, nanocarriers with appropriate physicochemical characteristics such as dimensions and surface charge have been recently investigated as delivery systems able to protect drugs from enzymatic degradation, improve drug pharmacokinetics and enter cells and various cellular compartments [5-7].”
BackgroundMagalhães, M., Figueiras, A., & Veiga, F. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813627-0.00007-7 · Cited by 11
Wang, H., Calubaquib, E. L., Bhadran, A., Ma, Z., Miller, J. T., Zhang, A., Biewer, M. C., & Stefan, M. C. (2022) · Polymer Chemistry · doi:10.1039/d2py01444k · Cited by 10
Nanocarrier Mediated Intranasal Drug Delivery Systems for the Management of Parkinsonism: A Review
Kapoor, A., Hafeez, A., & Kushwaha, P. (2023) · Current Drug Delivery · doi:10.2174/1567201820666230523114259 · Cited by 10
Suleman, M., Sayaf, A. M., Khan, A., Khan, S. A., Albekairi, N. A., Alshammari, A., Agouni, A., Yassine, H. M., & Crovella, S. (2024) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2024.05.005 · Cited by 10
Yazdan, M., Naghib, S. M., & Mozafari, M. R. (2024) · Current Drug Targets · doi:10.2174/0113894501294136240610061328 · Cited by 10
Nanotherapy for Neural Retinal Regeneration
Yu, C., Dong, L., Lv, Y., Shi, X., Zhang, R., Zhou, W., Wu, H., Li, H., Li, Y., Zhou, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202409854 · Cited by 13
Nanotherapeutics as promising approaches to combat fungal infections
Kamel, R. (2019) · Drug Development Research · doi:10.1002/ddr.21533 · Cited by 10
Switching from endogenous to exogenous delivery of a model drug to DNA through micellar engineering
Kundu, P., Das, S., & Chattopadhyay, N. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111765 · Cited by 10
Virus as a Nanocarrier for Drug Delivery Redefining Medical Therapeutics - A Status Report
Ojha, S. K., Kumar, S., Pattnaik, R., Singh, P. K., Dixit, S., Mishra, S., & Pal, S. (2020) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207323666201218115850 · Cited by 11
Design, Synthesis, and Functionalization of Nanomaterials for Therapeutic Drug Delivery
Grandhi, T. S. P., & Rege, K. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8739-0_9 · Cited by 10
Iqbal, S., Zhang, Y., Liu, Y., Akram, R., & Lv, S. (2016) · Chemical Engineering Journal · doi:10.1016/j.cej.2016.02.096 · Cited by 10
Rostami, M. R., Hassanzadeh, F., Farzan, M., Varshosaz, J., Khodarahmi, G., & Maaleki, S. (2017) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.202449 · Cited by 11
“Polymeric micelles (PMs) due to their suitable characteristic features could improve the pharmacokinetic and pharmacodynamic properties such as increased plasma half-life, protection from enzymes, enhanced permeation and solubility (1).”
Nanotechnology in Oral Drug Delivery: Salient Aspects, State of Art, and Applications
Patel, M., Joshi, G., & Sawant, K. K. (2020) · Nanotechnology in the life sciences · doi:10.1007/978-3-030-41464-1_8 · Cited by 12
Italiya, K. S., Singh, A. K., Chitkara, D., & Mittal, A. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01980-5 · Cited by 10
“Although polymeric micelles provided considerable control over the PK and pharmacodynamics (PD) of LSF owing to their nano-size, enhanced surface area and shielding the ester linkage in LSF-LA in the acidic GI fluid; nonetheless, administration of these nano-sized particles to the patients still remains a challenge (1…”
BackgroundTinku, Prajapati, A. K., & Choudhary, S. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.118303 · Cited by 10
Nanotechnology-Based Drug Delivery System
Bhutta, Z. A., Shoaib, M., Kanwal, A., Ashar, A., Mahfooz, A., Huma, H., Ahmed, R., Ali, M., Kulyar, M. F., & Li, K. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-7998-8908-3.ch005 · Cited by 12
Nanotherapeutics for Meningitis: Enhancing Drug Delivery Across the Blood-Brain Barrier
Sharma, H., Narayanan, K. B., Ghosh, S., Singh, K. K., Rehan, P., Amist, A. D., Bhaskar, R., & Sinha, J. K. (2025) · Biomimetics · doi:10.3390/biomimetics10010025 · Cited by 11
“The transition from laboratory-scale synthesis to large-scale manufacturing is often challenging because the nanoparticle properties are sensitive to production conditions such as mixing, temperature, and solvent interactions [32,102].”
Discovery of novel PARP1 inhibitors through computational drug design approaches
Shamim, M., Ali, M. S., Hossain, M. A., Hossain, M. A., Kavey, M. R. H., Hoque, M. M., Rahman, M. A., Harrath, A. H., & Rahman, M. H. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108366 · Cited by 10
Shaw, I., Boafo, G. F., Ali, Y. S., Liu, Y., Mlambo, R., Tan, S., & Chen, C. (2024) · Journal of Microencapsulation · doi:10.1080/02652048.2024.2326091 · Cited by 12
“…them to be promising nanocarrier platforms for the site-specific delivery of anticancer drugs because of their advantages as delivery vehicles (Xu et al. 2013) (table 1). it is economical and easy to produce nano-sized particles that are stable, monodisperse, and can easily be modified to…”
BackgroundGuo, Q., Cai, J., Li, P., Xu, D., Ni, X., Wen, H. X., Liu, D., Lin, S., & Hu, H. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s119918 · Cited by 9
“It was reported that higher BS/PC ratio enables BSs to exist around the PC bilayers and also within the interior, which is advantageous for the solubilization of drugs that have similar structures to BSs.2 Therefore, in our study, higher solubilizing capacity of SBA-Na/PC could be interpreted by that it possesses more…”
BackgroundInfluentialNANOPLEX: A REVIEW OF NANOTECHNOLOGY APPROACH FOR SOLUBILITY AND DISSOLUTION RATE ENHANCEMENT
Kasar, P. M., Kale, K. S., & Phadtare, D. G. (2018) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2018v10i4.28467 · Cited by 9
“Micelles are formed in aqueous solutions when the concentration of the block copolymer increases above a certain concentration or critical micelle concentration [22].”
BackgroundBiomedical Applications of Nanostructured Polymeric Materials
Stevanović, M. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816771-7.00001-6 · Cited by 13
Harrison, T. D., Salmon, A. J., de Bruyn, J. R., Ragogna, P. J., & Gillies, E. R. (2020) · Langmuir · doi:10.1021/acs.langmuir.0c01370 · Cited by 9
Recent Advances in the Local Drug Delivery Systems for Improvement of Anticancer Therapy
Arora, S., Singh, D. P., Kaur, P., Attri, S., Singh, S., Sharma, P., Mohana, P., Kaur, K., Kaur, H., Singh, G., et al. (2021) · Current Drug Delivery · doi:10.2174/1567201818666211214112710 · Cited by 9
Recent Updates on Polymeric Micelles: A Review
Pawar, A., Kamdi, V., Alaspure, A., & Gangane, P. S. (2022) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2022.v73i01.010 · Cited by 12
Stouten, J., Sijstermans, N., Babilotte, J., Pich, A., Moroni, L., & Bernaerts, K. V. (2022) · Polymer Chemistry · doi:10.1039/d2py00631f · Cited by 9
Polymeric and liposomal nanomaterials
Bueno, C. Z., de Oliveira, C. A., & Rangel‐Yagui, C. D. O. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100716-7.00017-9 · Cited by 10
Antibreast Cancer Activity of Aspirin-Conjugated Chalcone Polymeric Micelles
Lee, D. Y., Lee, K. P., Beak, S., Park, J. S., Kim, Y. J., Kim, K., Kim, S., & Yoon, M. S. (2021) · Macromolecular Research · doi:10.1007/s13233-021-9010-y · Cited by 9
Introduction to Nanoparticulate Drug Delivery Systems
Patel, J. K., Patel, A., Patel, M., & Vyas, G. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-83395-4_1 · Cited by 10
Biocompatible Polymers and Their Applications
Sharma, S. C., Aiswarya, T., Mirza, I., & Saha, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820352-1.00044-4 · Cited by 14
Zhao, Y., Zhang, H., Wu, P., Tan, D., Zhao, Y., Zhang, C., Wang, J., Bai, B., An, J., & Shi, C. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01068 · Cited by 9
Malkawi, A. S., Haddad, R. H., Malkawi, A., & Alrabadi, N. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220314103400 · Cited by 8
Nanotube platforms for effective drug delivery applications
Adetunji, C. O., Ogundolie, F. A., Mathew, J. T., Inobeme, A., Titilayo, O., Olaniyan, O. T., Ghazanfar, S., Ijabadeniyi, O. A., Ajiboye, M. D., Ajayi, O. O., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00005-7 · Cited by 11
Radhakrishnan, A., Shanmukhan, N. K., & Samuel, L. C. (2025) · Medical Oncology · doi:10.1007/s12032-025-02611-w · Cited by 8
“With the improved drug solubility and ability to protect the drug from GI with prolonged drug circulation, self-assembled polymeric micelles (PMs), having a core–shell micellar structure, served as a promising tool to increase oral bio-availability [178].”
Medicinal Chemistry of Inhibitors Targeting Resistant Bacteria
Monteiro, K. L. C., Silva, O. N., Nascimento, I. J. D. S., Mendonça, F. J. B., Aquino, P. G. V., da Silva‐Júnior, E. F., & de Aquino, T. M. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220321124452 · Cited by 10
Drug Solubilization and Drug Release from Polymeric Micelles
Vambhurkar, G. B., Jain, N., Srinivasarao, D. A., Famta, P., Singh, S. B., & Srivastava, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-0361-0_5 · Cited by 12
Waghmare, P., Chabukswar, A. R., Raut, K., Gaikwad-Pawar, B., & Jagdale, S. C. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00236 · Cited by 10
Solubilization of lignin in copolymer micelles in aqueous solution
Azadfar, M., Hiscox, W. C., & Chen, S. (2016) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2016.05.031 · Cited by 8
Medical devices that look like medicines: safety and regulatory concerns for children in Europe
Huijghebaert, S., Bruyne, P. D., Allegaert, K., Velde, S. V., Bruyne, R. D., Biervliet, S. V., & Winckel, M. V. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316391 · Cited by 11
“88 96 DIsCussIOn EU marketing of barrier-claiming MedDevs for repeated oral use only requires national notification, bypassing the in-depth critical expert review by medicinal authorities.”
Ganna, S., Reddy, G. R., Borelli, D. P., Rao, K. M., Mallikarjuna, K., & Nannepaga, J. S. (2021) · Polymer Bulletin · doi:10.1007/s00289-020-03494-9 · Cited by 8
Razzaq, S., Rauf, A., Raza, A., Tabish, T. A., Hassan, M. R. U., & Shahnaz, G. (2021) · Polymers for Advanced Technologies · doi:10.1002/pat.5330 · Cited by 8
Pharmaceutical Applications of Vitamin E TPGS
Jasim, A. M., & Jawad, M. J. (2021) · Biochemistry · doi:10.5772/intechopen.97474 · Cited by 9
Advanced drug delivery systems to treat Huntington’s disease: challenges and opportunities
Vishwas, S., Gulati, M., Khursheed, R., Arya, K. R., Singh, S. K., Jha, N. K., Prasher, P., Kumar, D., & Kumar, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99616-7.00005-0 · Cited by 10
Low, Y. Z., Li, L., & Tan, L. P. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01187 · Cited by 8
Vyas, J., Bhalani, D., Ansari, R., Ray, D., Aswal, V. K., & Pillai, S. A. (2025) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2025.101991 · Cited by 7
Pop, M., & Botiz, I. (2025) · Materials · doi:10.3390/ma18194580 · Cited by 7
Nanocarriers and their Types for Targeted Drug Delivery
Shaik, N., & Prasanth., Y. (2022) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2022.v77i01.004 · Cited by 11
Uddin, A., Halder, S., Deb, N., Das, H., Shuma, M. L., Hasan, I., Shill, M. C., & Haider, S. S. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2024/2303942 · Cited by 7
“According to the micellar size distribution, the size of micelles plays a considerable role in how they enter diferent cells in vivo , regardless of the route of administration [42].”
BackgroundNanocarriers in drug delivery system: Eminence and confront
Sultana, N., Bora, P., & Sarma, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-816770-0.00010-1 · Cited by 11
Modulated approaches for strategic transportation of proteins and peptides via ocular route
Bhatt, M., & Shende, P. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102835 · Cited by 7
Recent Advances of Nanotechnology in Brain Targeting
Dewangan, H. K., Singh, V., Garg, A., & Sharma, R. K. (2022) · Current Nanoscience · doi:10.2174/1573413718666220820113550 · Cited by 16
Bhattacharjee, B., Ikbal, A. M. A., Farooqui, A., Sahu, R. K., Ruhi, S., Syed, A., Miatmoko, A., Khan, D., & Khan, J. (2023) · Chemical Papers · doi:10.1007/s11696-023-02795-3 · Cited by 7
“These micelles can be synthesized by precipitating one block and adding a solvent and direct dissolution of polymer in a convenient solvent-based followed by dialysis (Cho et al. 2015; Xu et al. 2013).”
BackgroundPolymeric Nanocarriers for the Delivery of Phytoconstituents
Verma, K., Chaturvedi, A., Paliwal, S., Dwivedi, J., & Sharma, S. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-5314-1_4 · Cited by 7
Suleman, M., Murshed, A., Imran, K., Khan, A., Ali, Z., Albekairi, N. A., Wei, D., Yassine, H. M., & Crovella, S. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01185-4 · Cited by 7
“Notably, the efficacy of drug absorption hinges on water solubility, with heightened solubility indicating enhanced absorption features and heightened bioavailability [66].”
BackgroundEzhumalai, N., Nandhagopal, M., Kasthuri, J., & Rajendiran, N. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135085 · Cited by 7
Polyacrylamide and related polymers
Kavitha, A. A., & Anilkumar, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00008-8 · Cited by 7
Crosslinked poly-γ-glutamic acid based nanosystem for drug delivery
Csikós, Z., Fazekas, E., Rózsa, D., Borbely, J. D., & Kerekes, K. (2018) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.026 · Cited by 7
Drug Delivery Systems Based on Polymeric Micelles
Khot, P., Nangare, K., Payghan, V., Kamble, T., & Payghan, S. (2022) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2022.00007 · Cited by 9
Ibi, A., Chang, C., Kuo, Y. C., Zhang, Y., Do, P., Du, M., Roh, Y. S., Gahler, R. J., Hardy, M. L., & Solnier, J. (2025) · Antioxidants · doi:10.3390/antiox14111313 · Cited by 6
“Micellar systems are known to enhance dispersion of lipophilic compounds, protect them from enzymatic conjugation, and potentially reduce efflux via transporters such as MRP2 and BCRP [31,32,50].”
Empowering the Battle: Bioenhancers as Allies Against Cancer Drug Resistance
Jadhav, P. V., Naga Jothi Prasath, V. R., Gajbhiye, S. G., Rane, U. A., Agnihotri, T. G., Gomte, S. S., & Jain, A. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010192038231107051715 · Cited by 6
Shaikh, R., & Bhattacharya, S. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673306752240726104241 · Cited by 9
Parseghian, L., Kahrarian, N., Arabanian, A. S., Alvand, Z. M., Massudi, R., Rahimi, M., & Rafati, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37283 · Cited by 6
“Thus, developing a novel drug delivery mechanism is imperative to enhance its delivery and bioavailability [16].”
BackgroundSuleman, M., Sayaf, A. M., Aftab, S., Alissa, M., Alghamdi, A., Alghamdi, S. A., Alshehri, M. A., Yeoh, K. K., Crovella, S., & Shaito, A. A. (2025) · Pharmaceuticals · doi:10.3390/ph18040602 · Cited by 6
“Assessing ADMET properties plays a crucial role in mitigating safety risks, enhancing effectiveness, and making informed decisions during drug development [59–61].”
Metadata
- Authors
- Xu, W., Ling, P., & Zhang, T.
- Affiliations
- Shandong University (CN)
- Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China
- Corresponding author
- Ling, Peixue
- ORCID
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2013-06-27
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- PMC
- PMC3712247
- OpenAlex
- W2061955697
- Cited by
- 595
- References
- 181
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 50 · 2023: 60 · 2022: 74 · 2021: 70 · 2020: 56 · 2019: 49 · 2018: 41 · 2017: 43 · 2016: 32 · 2015: 22 · 2014: 18 · 2013: 1
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Drug Delivery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, oral drug delivery, bioavailability enhancement, poorly water-soluble drugs, mucoadhesion, pH-responsive micelles, controlled drug release, P-glycoprotein inhibition, efflux pump inhibition, drug stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.